Home › Diffuse Large B-Cell Lymphoma › California › Sacramento
Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Sacramento, CA
Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Sacramento. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Nagre-recruitPhase 3
- UC Davis Comprehensive Cancer Center, Sacramento
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Nagre-recruitPhase 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Nagre-recruitPhase 2
- University of California, Davis Comprehensive Cancer Center, Sacramento
Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Nagre-recruitPhase 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Nagre-recruitPhase 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
Nagre-recruitPhase 2
- University of California Davis Comprehensive Cancer Center, Sacramento
Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Nagre-recruitPhase 2
- University of California Davis Comprehensive Cancer Center, Sacramento
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Nagre-recruitPhase 1/2
- University of California Davis Comprehensive Cancer Center, Sacramento
Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod
- New York City, NY21 pag-aaral
- Baldwin Park, CA19 pag-aaral
- Chicago, IL18 pag-aaral
- Los Angeles, CA17 pag-aaral
- Houston, TX17 pag-aaral
- Boston, MA16 pag-aaral
- Milwaukee, WI16 pag-aaral
- Portland, OR15 pag-aaral
- Philadelphia, PA15 pag-aaral
- Durham, NC14 pag-aaral
- Nashville, TN14 pag-aaral
- Dallas, TX13 pag-aaral
Iba pang pag-aaral sa Sacramento
- Non-Small Cell Lung Cancer29 pag-aaral
- Kanser sa Baga22 pag-aaral
- Kanser sa Suso20 pag-aaral
- Kanser sa Prostate19 pag-aaral
- Metastatic Cancer16 pag-aaral
- Kanser (lahat ng uri)12 pag-aaral
- Kanser sa Pancreas12 pag-aaral
- Acute Myeloid Leukemia12 pag-aaral
- Pagkabigo ng Puso12 pag-aaral
- Colorectal Cancer10 pag-aaral
- Colon Cancer10 pag-aaral
- Kanser sa Pantog10 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.